<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/E4B27ADA-EDE5-41A2-ABED-CB57FA57DCAD"><gtr:id>E4B27ADA-EDE5-41A2-ABED-CB57FA57DCAD</gtr:id><gtr:name>MRC Laboratory for Molecular Cell Biology (LMCB)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/773AC409-21D1-4CA0-87AA-1769A45D718E"><gtr:id>773AC409-21D1-4CA0-87AA-1769A45D718E</gtr:id><gtr:name>Free University of Brussels (VUB)</gtr:name><gtr:address><gtr:line1>Pleinlaan 2</gtr:line1><gtr:postCode>B-1050</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Belgium</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/A7048098-BFD5-48FC-94EA-F57032099A95"><gtr:id>A7048098-BFD5-48FC-94EA-F57032099A95</gtr:id><gtr:name>National Research Council CNR - Italy</gtr:name><gtr:address><gtr:line1>National Research Council CNR</gtr:line1><gtr:line2>P le Aldo Moro 7</gtr:line2><gtr:line4>Rome</gtr:line4><gtr:line5>00185</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Italy</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>Pharmacology</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/E4B27ADA-EDE5-41A2-ABED-CB57FA57DCAD"><gtr:id>E4B27ADA-EDE5-41A2-ABED-CB57FA57DCAD</gtr:id><gtr:name>MRC Laboratory for Molecular Cell Biology (LMCB)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/773AC409-21D1-4CA0-87AA-1769A45D718E"><gtr:id>773AC409-21D1-4CA0-87AA-1769A45D718E</gtr:id><gtr:name>Free University of Brussels (VUB)</gtr:name><gtr:address><gtr:line1>Pleinlaan 2</gtr:line1><gtr:postCode>B-1050</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Belgium</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/A7048098-BFD5-48FC-94EA-F57032099A95"><gtr:id>A7048098-BFD5-48FC-94EA-F57032099A95</gtr:id><gtr:name>National Research Council CNR - Italy</gtr:name><gtr:address><gtr:line1>National Research Council CNR</gtr:line1><gtr:line2>P le Aldo Moro 7</gtr:line2><gtr:line4>Rome</gtr:line4><gtr:line5>00185</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Italy</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/6DF6EBA7-88E8-4A28-8887-9E77FCE1708C"><gtr:id>6DF6EBA7-88E8-4A28-8887-9E77FCE1708C</gtr:id><gtr:firstName>Catherine</gtr:firstName><gtr:surname>Lindon</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=MR%2FM01102X%2F1"><gtr:id>2773102A-8088-4852-A7B6-113AB7A7C98D</gtr:id><gtr:title>Ubiquitin-mediated events in cell fate decisions</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>MR/M01102X/1</gtr:grantReference><gtr:abstractText>The most critical decision that a cell takes when it divides is whether to go ahead and divide again as soon as possible (making more cells), or not to divide for now. Errors in making this decision of cell fate cause cancer and other diseases of cell proliferation.
Our general objective is to understand the molecular regulation of pathways that control the cell division cycle in human cells. These pathways are essential, during and after cell division, to generate daughter cells with correct chromosome numbers, correct cell architecture and correct control of future division decisions. We have developed techniques that allow us to probe critical events that involve modification of cellular components through a process known as ubiquitination. Our pilot study has shown that many ubiquitin-mediated pathways control events immediately following cell division and are likely to influence or determine the decision to divide again.
We propose research that studies ubiquitination of cellular components in cells committed to the two alternative cell fates. This can provide us with a better understanding of cancer. Current cancer treatments that target dividing cells do not distinguish between dividing cancer cells and dividing healthy cells that retain control over their cell fate. Therefore the ability to distinguish dividing cells with different fates would lead to better targeting of future therapies.</gtr:abstractText><gtr:technicalSummary>Recent work in the field has demonstrated that cell fate choices are not restricted to G1 phase, since cells exit mitosis already committed to enter a subsequent round of cell division. Our own recent work has identified cellular components that are specifically ubiquitinated during the wave of proteolysis that accompanies exit from mitosis. Many of these components are predicted to be involved in rebuilding the interphase cell, and we hypothesize that ubiquitination of these components contributes to organization of the interphase cell in a way that depends on cell fate. We propose here to identify components that are specifically targeted in cells of differing fate, and to understand 1) how they are targeted 2) how their ubiquitination contributes to interphase 3) how their ubiquitination marks and influences cell fate choices.</gtr:technicalSummary><gtr:potentialImpactText>Our research will have beneficiaries within academia and within the commercial sector (biotechnology, pharmaceutical) sectors and will benefit the general public on various timescales.
Academia will benefit through our acquisition and dissemination of new knowledge, through training of young scientists and future scientists in a world-class environment and through the new tools and methodology that we will generate, that will be shared with fellow academics upon request.
The commercial sector will benefit through new knowledge of cellular mechanisms important to disease and to treatment of disease. Moreover, the critical methodologies that we develop and promote in this research (purification of ubiquitin conjugates via a biotin tag, measurement of protein turnover via tandem Fluorescent Protein Timers, tFTs) are highly exploitable for drug discovery in ubiquitin-mediated pathways.
The general public will benefit on different timescales: In the short term, they will benefit from our dissemination and outreach activities aimed to engage a wider audience with our research. In the medium term from the training we provide that will contribute to the global future of science. In the long term, from the discovery and exploitation of new therapeutic pathways in cancer or benign proliferative diseases such as arthritis, psoriasis.</gtr:potentialImpactText><gtr:fund><gtr:end>2018-11-30</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2015-07-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>450975</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Research Council (CNR)</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:description>Targeting Aurora A stability in cancers through its interaction with TPX2</gtr:description><gtr:id>F46274A5-8A0F-40E2-957B-177C15AF4465</gtr:id><gtr:impact>http://dx.doi.org/10.1016/j.bbcan.2010.08.001
http://dx.doi.org/10.1242/jcs.075457</gtr:impact><gtr:partnerContribution>We have exchanged reagents &amp;amp; ideas &amp;amp; conducted experiments towards joint publications. An ex-student from Dr Guarguaglini's lab came to work as my research assistant when my postdoc left after working out her maternity leave.</gtr:partnerContribution><gtr:piContribution>We have exchanged reagents &amp;amp; ideas &amp;amp; conducted experiments towards joint publications, with Dr Giulia Guarguaglini and her lab. We are planning further publications together in the next 3 years.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Free University of Brussels (Vrije Universiteit Brussel)</gtr:collaboratingOrganisation><gtr:country>Belgium, Kingdom of</gtr:country><gtr:description>Role of deubiquitinases in regulating mitotic targets</gtr:description><gtr:id>08B088E0-0337-4FA3-B398-B687F12788C7</gtr:id><gtr:impact>Very exciting preliminary data</gtr:impact><gtr:partnerContribution>Providing molecular reagents for cell-based assays of a DUB targeting Aurora kinases</gtr:partnerContribution><gtr:piContribution>Providing imaging facilities for cell-based assays of a DUB targeting Aurora kinases</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>MRC Laboratory for Molecular Cell Biology (LMCB)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Testing K11-ubiquitin linkages on Aurora kinases</gtr:description><gtr:id>AD5D891B-AC1A-42FD-A014-D6CB497CC2FD</gtr:id><gtr:impact>Publication Min et al. (2015). doi: 10.1091/mbc.E15-02-0102</gtr:impact><gtr:partnerContribution>DUBs restriction assays on ubiquitinated material conjugated on Aurora kinases from mitotic cells</gtr:partnerContribution><gtr:piContribution>Purifying ubiquitinated Aurora kinases from human cells for testing in DUBs restriction assay for ubiquitin linkage types</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Science Festival display</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>95A0F630-EA0D-4570-A6C5-30EE650DDAB0</gtr:id><gtr:impact>Cambridge Science Festival 'Highlighting Biology' event designed by my lab and hosted along with colleagues from the Department of Genetics in the Plant and Life Sciences Marquee. Purpose to explain and illustrate the use of GFP in cell biology, with opportunity for hands-on activity. Our display featured in the October 2016 edition of The Biologist magazine of Royal Society of Biology, which had awarded funds for this event. The Plant and Life Sciences Marquee exhibits received a Cambridge BID (Business Improvement District) Award in 2016 for exceptional customer experience.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.phar.cam.ac.uk/news/pharmsciencefestival</gtr:url><gtr:year>2016,2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Senior Members' Research Forum (SMRS)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>09264D82-94C5-4867-BA6F-C38EA1C16E17</gtr:id><gtr:impact>Informal seminar to academics from all research fields at Newnham College</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Other audiences</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Work experience for Yr 11 and 12 students</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>31EE2808-D1F6-438D-979D-D3357BB639B5</gtr:id><gtr:impact>Two students, one from London and the other from Kent, spent one week in the lab shadowing lab members and carrying out simple experiments on the microscope.
Both of the students are keen to study science at University. The Year 12 student went on to secure a University place to study Biochemical Engineering, the other will make her UCAS applications later this year.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>85000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC targeted DTP studentship</gtr:description><gtr:end>2020-09-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>66707C91-169F-4E6E-B5E3-2A37535F3E39</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2016-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D2F027F0-D278-4CC8-BD3F-7F1191118A85"><gtr:id>D2F027F0-D278-4CC8-BD3F-7F1191118A85</gtr:id><gtr:title>Isolation of Ubiquitinated Proteins to High Purity from In Vivo Samples.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4b50ad2711a8f5b6ce0c59d5c19e3df2"><gtr:id>4b50ad2711a8f5b6ce0c59d5c19e3df2</gtr:id><gtr:otherNames>Ramirez J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/AA45269A-EA56-4595-9851-47F8029BD655"><gtr:id>AA45269A-EA56-4595-9851-47F8029BD655</gtr:id><gtr:title>Ubiquitin-Mediated Degradation of Aurora Kinases.</gtr:title><gtr:parentPublicationTitle>Frontiers in oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/320d2d43ada4844b2834d0ecd84e29be"><gtr:id>320d2d43ada4844b2834d0ecd84e29be</gtr:id><gtr:otherNames>Lindon C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2234-943X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8AA3B77D-E9CB-4466-9448-0900516BB20D"><gtr:id>8AA3B77D-E9CB-4466-9448-0900516BB20D</gtr:id><gtr:title>Efficient APC/C substrate degradation in cells undergoing mitotic exit depends on K11 ubiquitin linkages.</gtr:title><gtr:parentPublicationTitle>Molecular biology of the cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/816ef8b1b2073b67a9afcf678ca5a97f"><gtr:id>816ef8b1b2073b67a9afcf678ca5a97f</gtr:id><gtr:otherNames>Min M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1059-1524</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MR/M01102X/1</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>